Turn Therapeutics Inc. Common Stock Market Cap ($293.05 Million)
Market Cap & Net Worth: Turn Therapeutics Inc. Common Stock (TTRX)
Turn Therapeutics Inc. Common Stock market cap. Turn Therapeutics Inc. Common Stock (NASDAQ:TTRX) has a market capitalization of $293.05 Million ($293.05 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14671 globally and #3501 in its home market, demonstrating a -6.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Turn Therapeutics Inc. Common Stock's stock price $9.65 by its total outstanding shares 30367704 (30.37 Million). Also see Turn Therapeutics Inc. Common Stock cash conversion from operations for how efficiently the company converts equity into cash flow.
Turn Therapeutics Inc. Common Stock Market Cap History (2025–2026)
Turn Therapeutics Inc. Common Stock market cap history from 2025 to 2026. Data shows growth from $119.65 Million to $293.05 Million (0.00% CAGR). Check TTRX live share price for real-time trading data and today's change.
Turn Therapeutics Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Turn Therapeutics Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Turn Therapeutics Inc. Common Stock net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TTRX by Market Capitalization
Companies near Turn Therapeutics Inc. Common Stock in the global market cap rankings as of November 3, 2026. Also see how large is Turn Therapeutics Inc. Common Stock's balance sheet for a full breakdown of the balance sheet.
Key companies related to Turn Therapeutics Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Turn Therapeutics Inc. Common Stock (2025–2026)
Market capitalization of Turn Therapeutics Inc. Common Stock from 2025 to today. Between 2025 and today, Turn Therapeutics Inc. Common Stock's market cap moved from $119.65 Million to $ 293.05 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $293.05 Million | +144.92% |
| 2025 | $119.65 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Turn Therapeutics Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $293.05 Million USD |
| MoneyControl | $293.05 Million USD |
| MarketWatch | $293.05 Million USD |
| marketcap.company | $293.05 Million USD |
| Reuters | $293.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and de… Read more